Fri, Mar 29 | Goodes Hall-Room 305, Queen's University

(KINGSTON CHAPTER) How to Transition from Biological Sciences to Business

Join the Kingston Chapter and head of JLABS Canada, Allan Miranda, to discuss the transition from biological sciences to business.
Registration is Closed

Time & Location

Mar 29, 2019, 1:00 PM – 2:00 PM
Goodes Hall-Room 305, Queen's University, Goodes Hall, 143 Union St W, Kingston, ON K7L 2P3, Canada

About the Event

Join the Kingston Chapter of the S2BN and the head of JLABS Canada, Allan Miranda, to learn how to apply your academic skills to the business world, discuss how to navigate through this world from a science perspective, and discover how scientific innovation can promote the life sciences sector.

Click here for specific directions to Room 305 Goodes Hall

Allan Miranda received his Ph.D. in Neuropharmacology from Queen's University at Kingston, Ontario and his MBA from McGill University in Finance and Strategy. He is currently the Head of Johnson & Johnson Innovation, JLABS in Canada. Allan is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. He catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.

Allan joined the JLABS team from Janssen Canada, where he has spent the last 12 years in positions of increasing responsibility in business development, marketing and market access. His most recent role was Therapeutic Lead Immunology and Primary Care where he was responsible for market access strategy for a complex product portfolio exceeding $1 billion. Allan started his career at PARTEQ Innovations, the technology transfer arm of Queen's University at Kingston where he was responsible for technology assessment and new company start-up. He then moved to Paladin Labs, where he successfully completed numerous in-licensing transactions for specialty pharmaceutical products for the Canadian market. Allan subsequently worked in business development for two early stage biotechnology companies in Canada leading their business development and partnering initiatives prior to joining Janssen.

Registration is Closed

Share This Event

S2BN

Follow Us

  • Grey Instagram Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon

Contact Us

Subscribe to the S2BN 

© Copyright 2019 by Science to Business Network. 

S2BN is Supported by: Bayer Canada, BioTalent Canada & Cyclica Inc.